InspireMD ( (NSPR) ) has provided an announcement.
InspireMD, Inc. has established its global headquarters in Miami, Florida, marking a critical move to support the anticipated U.S. launch of its CGuard Prime carotid stent system in 2025. This new base is strategically located to leverage South Florida’s resources and talent pool, aiding in building a robust commercial and operational team to drive growth and expand market presence. As they gear up for potential FDA approval, InspireMD aims to capitalize on this expansion to enhance shareholder value and meet growing demand in the U.S. market.
Find detailed analytics on NSPR stock on TipRanks’ Stock Analysis page.
